Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | IDE | P14735 | 1/20 | 0.48 |
| ▸ | MYC | P01106 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 10/20 | 0.42 |
| ▸ | MEN1 | O00255 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2266902 | 1.00 | ALDH1A1 (0.52) | ALDH1A1ALOX15IDEMYCMAPT | |
| SCHEMBL10385043 | 0.90 | IDE (0.59) | ALDH1A1ALOX15IDEMYCMAPT | |
| SCHEMBL10385044 | 0.90 | IDE (0.59) | ALDH1A1ALOX15IDEMYCMAPT | |
| SCHEMBL12949078 | 0.84 | ALDH1A1 (0.50) | ALDH1A1ALOX15IDEMAPTMEN1 | |
| SCHEMBL11511140 | 0.80 | MYC (0.76) | ALDH1A1IDEMYCMAPTMEN1 | |
| SCHEMBL422 | 0.79 | ALDH1A1 (0.67) | ALDH1A1ALOX15MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL7238211 | 0.79 | KMT2A (0.50) | ALDH1A1IDEMYCMAPTMEN1 | |
| SCHEMBL7238207 | 0.79 | KMT2A (0.50) | ALDH1A1IDEMYCMAPTMEN1 | |
| SCHEMBL4798110 | 0.79 | ALDH1A1 (0.45) | ALDH1A1ALOX15IDEMAPTKDM4E | |
| SCHEMBL2137249 | 0.79 | ALDH1A1 (0.45) | ALDH1A1ALOX15IDEMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108263177-A | A kind of shield glass | 重庆染色体科技发展有限公司 | 2018-07-10 | — | — | CN | claimed |
| CN-108263177-A | A kind of shield glass | 重庆染色体科技发展有限公司 | 2018-07-10 | — | — | CN | disclosed |
| CN-103193967-B | A kind of preparation method of hyperbranched azobenzene polymer and application thereof | JIANGSU UNIVERSITY (CN) | 2015-08-05 | — | — | CN | disclosed |
| CN-103193967-B | A kind of preparation method of hyperbranched azobenzene polymer and application thereof | JIANGSU UNIVERSITY (CN) | 2015-08-05 | — | — | CN | disclosed |
| EP-2651917-A1 | DIMERIC IAP INHIBITORS | Novartis AG (CH) | 2013-10-23 | — | — | EP | disclosed |
| US-20130266590-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2013-10-10 | — | — | US | disclosed |
| CN-103193967-A | Preparation method and applications of hyperbranched azo polymer | UNIV JIANGSU | 2013-07-10 | — | — | CN | disclosed |
| US-8445440-B2 | Dimeric IAP inhibitors | NOVARTIS AG (CH) | 2013-05-21 | — | — | US | disclosed |
| EP-2539333-A1 | DIMERIC IAP INHIBITORS | Novartis AG (CH) | 2013-01-02 | — | — | EP | disclosed |
| WO-2012080260-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2012-06-21 | — | — | WO | disclosed |
| WO-2011104266-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2011-09-01 | — | — | WO | disclosed |
| US-20110206690-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130266590-A1 | DIMERIC IAP INHIBITORS | XIAP, BIRC5, BIRC2 | ALDH1A1 4312/4885ALOX15 4561/4885IDE 207/4885 |
| US-20110206690-A1 | DIMERIC IAP INHIBITORS | XIAP, BIRC5, BIRC2 | ALDH1A1 4127/4885ALOX15 4343/4885IDE 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.